| News

ChemAxon establishes subsidiary in Basel

06.11.2020

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in Basel. The customer base and economic conditions were cited as reasons for the choice of location.

The Hungarian company ChemAxon has established the ChemAxon GmbH subsidiary in Basel. The software company chose Basel on account of the connection to customers in the chemicals and biopharma industries as well as the economic conditions. In setting up the new location, it was supported by Basel Area Business & Innovation, the investment and innovation promotion agency.

“During the evaluation process and after the incorporation period I was really impressed with all the support and help ChemAxon and I received from BaselArea Business & Innovation,” explains Annamaria Kovacs, the Basel-based representative of ChemAxon.

With headquarters in Budapest, ChemAxon also has offices in the USA, Prague and Asia. Worldwide, ChemAxon has 150 employees. The company’s software products help to accelerate and enhance scientific discovery and collaboration. The solutions are tailored to the requirements of customers in the chemicals and biopharma sectors.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Noema Pharma raises 54 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Noema Pharma raises 54 million Swiss francs

The Basel-based pharmaceutical company Noema Pharma has raised a total of 54 million Swiss francs as part of a Series...

Read More
Meteoblue constantly presents new developments
Basel Area Business & Innovation, Innovation, Invest

Meteoblue constantly presents new developments

The meteoblue weather service based in Basel has developed a weather map widget that can be embedded in any website....

Read More
Lonza manufactures coronavirus vaccine for Moderna
Basel Area Business & Innovation, Innovation, Invest

Lonza manufactures coronavirus vaccine for Moderna

Lonza plans to start production of Moderna’s coronavirus vaccine in Switzerland before the end of the year. Moderna published the...

Read More
Synendos raises 20 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Synendos raises 20 million Swiss francs

Synendos Therapeutics has concluded a Series A financing round, raising 20 million Swiss francs. The Basel biotech will use the...

Read More
Both Basel cantons are first class borrowers
Basel Area Business & Innovation, Invest

Both Basel cantons are first class borrowers

Standard & Poor’s has awarded the canton of Basel-City its top rating of AAA. The rating agency anticipates that Basel...

Read More
ChemAxon establishes subsidiary in Basel
Basel Area Business & Innovation, Innovation, Invest

ChemAxon establishes subsidiary in Basel

ChemAxon develops software for application in the chemicals and biopharma industries. Now, the Hungarian company has established a subsidiary in...

Read More
1 2 3 37

Do you have a question? We'd like to hear from you.